AxoGen, Inc. (AXGN) has a consensus analyst rating of Buy, based on 18 analysts covering the stock. Of those, 15 recommend buying, 3 recommend holding, and 0 recommend selling.
The analyst consensus price target for AXGN is $38.38, representing a +11.4% upside from the current price of $34.46. Price targets range from a low of $34.00 to a high of $41.00.
